Variant · Snv
SLC16A1 NM_003051.4(SLC16A1):c.362-21A>C
CI-VAR-00203339Explore in graph →NM_003051.4:c.362-21A>CClinVar 1332975 rs201021807
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1332975 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Ketoacidosis due to monocarboxylate transporter-1 deficiency; Metabolic myopathy due to lactate transporter defect; Exercise-induced hyperinsulinism; SLC16A1-related disorder; Uterine corpus endometrial carcinoma; Malignant lymphoma, large B-cell, diffuse; Cholangiocarcinoma; Familial cancer of breast | germline | 5 | Mar 10, 2022 | clinvar |